{"id":1490,"date":"2026-05-27T16:15:47","date_gmt":"2026-05-27T21:15:47","guid":{"rendered":"https:\/\/elyxaminos.com\/producto\/tesamorelin-10mg\/"},"modified":"2026-07-27T09:32:44","modified_gmt":"2026-07-27T14:32:44","slug":"tesamorelin-10mg","status":"publish","type":"product","link":"https:\/\/elyxaminos.com\/en\/producto\/tesamorelin-10mg\/","title":{"rendered":"Tesamorelin 10mg"},"content":{"rendered":"
\n

Tesamorelin 10mg<\/h2>\n

GHRH analog \u00b7 Visceral fat \u00b7 Endogenous IGF-1 \u00b7 Research Only<\/strong><\/p>\n

What is it and how does it work?<\/h3>\n

Tesamorelin is a stabilized synthetic analog of human growth hormone-releasing hormone (GHRH). It binds to the GHRH-R receptor on pituitary somatotrophs and stimulates pulsatile release of endogenous growth hormone, with documented increases in serum IGF-1 in clinical studies. The literature describes a preferential effect on abdominal visceral adipose tissue in cohorts with HIV-associated lipodystrophy.<\/p>\n

Clinical evidence: Falutz et al. (NEJM 2007, PMID 17984164) reported a reduction in visceral fat in patients with HIV-associated lipodystrophy following treatment with 2 mg\/day subcutaneous (SubQ) 15-20% for 26 weeks. Stanley et al. (JCI 2014, PMID 24911148) reported improvement in hepatic steatosis in nonalcoholic fatty liver disease. Research use only\u2014no FDA-approved human use outside the specific indication of HIV-associated lipodystrophy (Egrifta).<\/p>\n

Reconstitution and dosage<\/h3>\n
    \n
  • Vial<\/strong> 10 mg lyophilized<\/li>\n
  • Bacteriostatic water:<\/strong> 2 ml<\/li>\n
  • Resulting concentration:<\/strong> 5,000 mcg\/mL<\/li>\n
  • Per unit U-100:<\/strong> 50 mcg \u00b7 verification: 5,000 \u00f7 100 = 50 mcg\/u \u2713<\/li>\n
  • Conservation<\/strong> Refrigerate 2\u20138\u00b0C \u00b7 Use within 28\u201330 days after reconstituting<\/li>\n<\/ul>\n

    Volume Conversion Chart (U-100 syringe)<\/h3>\n\n\n\n\n\n\n\n
    U-100 equivalent<\/th>\nVolume<\/th>\nLoad (mcg)<\/th>\n<\/tr>\n<\/thead>\n
    25 years old<\/td>\n0.25 milliliters<\/td>\n1.25 mg<\/td>\n<\/tr>\n
    50 u<\/td>\n0.50 mL<\/td>\n2,500 mcg<\/td>\n<\/tr>\n
    100 u<\/td>\n1.00 mL<\/td>\n5,000 micrograms<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

    Documented evidence<\/h3>\n
      \n
    • Falutz J et al., NEJM 2007 (PMID 17984164) \u2014 Tesamorelin 2mg\/day SubQ \u00d7 26 wks reduces visceral fat in HIV lipodystrophy<\/li>\n
    • Stanley TL et al., JCI 2014 (PMID 24911148) \u2014 Improvement of hepatic steatosis<\/li>\n
    • Adrian S et al., Clin Infect Dis 2018\u2014Improvement in IGF-1 and Body Composition<\/li>\n<\/ul>\n

      Practical notes<\/h3>\n
        \n
      • Via documented in clinical literature: SubQ once daily (typically night)<\/li>\n
      • The effect on IGF-1 is dose-dependent; literature reports IGF-1 monitoring every 6-12 weeks<\/li>\n
      • Research Stack: Tesamorelin + CJC\/Ipa amplifies the GH axis; with BPC-157 for tissue regeneration<\/li>\n<\/ul>\n

        Contraindications and precautions<\/h3>\n
          \n
        • For research use only. No human use approved by FDA outside of Egrifta\u00ae for HIV lipodystrophy. No established safety data for other uses. Not for human use.<\/li>\n<\/ul>\n

          Research material only. Not approved for human use by the FDA.<\/strong> This product is intended for scientific research purposes in controlled laboratory settings only. It is not a drug. Not for human or animal administration, therapeutic use, or diagnostic use.<\/em><\/p>\n<\/section>","protected":false},"excerpt":{"rendered":"

          GHRH Analogue \u00b7 Visceral Fat \u00b7 Endogenous IGF-1 \u00b7 Research Only<\/strong><\/p>\n

            \n
          • Tesamorelin 10mg lyophilized for reconstitution with 2ml of bacteriostatic water<\/li>\n
          • Concentration: 5,000 mcg\/ml \u00b7 U-100 Dosage: 50 mcg\/u<\/li>\n
          • SubQ Route \u00b7 Refrigerated 2-8\u00b0C<\/li>\n
          • Research material only. Not approved for human use by the FDA.<\/li>\n<\/ul>","protected":false},"featured_media":1602,"comment_status":"open","ping_status":"closed","template":"","meta":[],"product_brand":[],"product_cat":[37],"product_tag":[],"class_list":{"0":"post-1490","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-fat-loss","8":"first","9":"instock","10":"shipping-taxable","11":"purchasable","12":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product\/1490","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/types\/product"}],"replies":[{"embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/comments?post=1490"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/media\/1602"}],"wp:attachment":[{"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/media?parent=1490"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product_brand?post=1490"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product_cat?post=1490"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/elyxaminos.com\/en\/wp-json\/wp\/v2\/product_tag?post=1490"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}